Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

NCT02467634 is registered in ClinicalTrials.gov with StemCells, Inc. as lead sponsor.

NCT NCT02467634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02467634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Proof-of-Concept Study of the Safety and Efficacy of HUCNS-SC Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration
Lead sponsor
StemCells, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
June 30, 2015
Completion date
May 31, 2016
Enrollment
3 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration